Xiaoqing Guan

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection

S. Perlman, Fang Li, L. Du, 2022, Journal of virology.

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines

L. Du, Yang Yang, Xiaoqing Guan, 2023, Expert review of vaccines.

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection

G. Wang, S. Perlman, Jiang Zhu, 2023, Virus Research.

SMYD2 Regulates Vascular Smooth Muscle Cell Phenotypic Switching and Intimal Hyperplasia via Interaction with Myocardin

Hang Shi, M. Zou, P. Song, 2023, Research square.

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge

G. Wang, Juan Shi, Xiaoqing Guan, 2023, iScience.

A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies

Yushun Wan, Wanbo Tai, Xiujuan Zhang, 2024, JCI insight.